Genocea Biosciences, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011
Total Revenue 731 1,977 1,820
Cost of Revenue - - -
Gross Profit 731 1,977 1,820
Operating Expenses
Research and Development 15,695 11,240 13,543
Sales, General and Admin. 4,961 3,690 3,004
Non-Recurring Items - - -
Other - - -
Operating Income (19,925) (12,953) (14,727)
Income From Continuing Operations
Add'l Income/Expense Items (422) 93 75
Earnings Before Interest and Tax (20,347) (12,860) (14,652)
Interest Expense 459 507 33
Earnings Before Tax (20,806) (13,367) (14,685)
Income Tax - - -
Minority Interest - - -
Equity Earnings Unconsolidated Subsidiary - - -
Net Income Cont. Operations (21,006) (13,367) (14,685)
Non Recurring Events
Discontinued Operations - - -
Extraordinary Items - - -
Effect of Accounting Changes - - -
Other Items - - -
Net Income (20,806) (13,367) (14,685)
Preferred Stock and Other Adjustments (1,605) (1,781) (1,605)
Net Income Applicable to Common Shareholders (22,411) (15,148) (16,290)